You are currently viewing a new version of our website. To view the old version click .

Translational Research on Exosomes in Cancer

This special issue belongs to the section “Cancer Biomarkers“.

Special Issue Information

Dear Colleagues,

Exosomes are actively secreted from living cells and found in body fluids as membrane-structured nanovesicles which contain bioactive molecules such as proteins, RNAs, and lipids. The content reflects the donor cells with their microenvironment and plays key endocrine and paracrine roles in the cell–cell communication of diverse biological processes important for both benign and cancer cells.

Circulating tumor-associated exosomes are still not completely understood but have potential as non-invasive novel biomarkers of (human) cancer, with critical roles already shown in contributing to tumorigenesis, metastasis, and chemotherapy resistance. Exosomes are detectable in body fluids such as blood, salvia, and urine, making them attractive as biomarkers for early cancer detection, diagnosis, and prognosis, and as therapeutic targets and drug delivery vehicles for cancer therapy.

This Special Issue is calling for reviews and original papers covering translational research on exosomes in cancer from basic science to clinical studies with a strong emphasis on improving the knowledge for clinical application.

Dr. Klaus Holzmann
Dr. Lingeng Lu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694